02.01.2019 Views

The Asian Independent - January 2019

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

www.theasianindependent.co.uk<br />

HEALTH<br />

<strong>January</strong> <strong>2019</strong><br />

15<br />

Diabetes drugs linked to heart disease risk: Study<br />

New York, Intake of<br />

two commonly used<br />

drugs to treat Type-2 diabetes<br />

carry a high risk of<br />

cardiovascular events<br />

such as heart attack,<br />

stroke, heart failure or<br />

amputation, warns a new<br />

study.<br />

<strong>The</strong> two drugs — sulfonylureas<br />

and basal<br />

insulin — are the second-line<br />

medication after<br />

metformin, a widely<br />

accepted initial Type-2<br />

diabetes treatment.<br />

<strong>The</strong> study, published<br />

in the journal JAMA<br />

Network Open, showed that<br />

patients who take one of these<br />

two drugs are 36 per cent more<br />

likely and twice as likely to<br />

experience cardiovascular<br />

harm.<br />

“People should know if the<br />

medications they are taking to<br />

treat their diabetes could lead to<br />

serious cardiovascular harm.<br />

This calls for a paradigm shift<br />

in the treatment of Type 2 diabetes,”<br />

said lead author<br />

Matthew O’Brien, Assistant<br />

Professor from the<br />

Northwestern University in the<br />

US. Physicians should consider<br />

prescribing newer classes of<br />

antidiabetic medications, such<br />

as GLP-1 agonists (liraglutide),<br />

SGLT-2<br />

inhibitors<br />

(empagliflozin)or DPP-4<br />

inhibitors (sitagliptin), more<br />

routinely after metformin,<br />

rather than sulfonylureas or<br />

basal insulin, suggest the<br />

researchers. <strong>The</strong>se drugs, however,<br />

are more expensive than<br />

the sulfonylureas, which is the<br />

main reason they are not as<br />

commonly prescribed.<br />

<strong>The</strong> study should force medical<br />

providers to think about<br />

cardiovascular effects of these<br />

drugs early in the course of diabetes<br />

treatment, and shift prescribing<br />

patterns to newer<br />

drugs that have more<br />

favourable cardiovascular profiles,the<br />

team noted.<br />

This was an observational<br />

study using data from 132,737<br />

patients with Type-2 diabetes<br />

who were starting second-line<br />

treatment.<br />

Novel drug to fight Alzheimer’s,<br />

PARKINSON’S DEVELOPED<br />

London, Scientists<br />

have developed a drug<br />

with potential to stop the<br />

breakdown of nerves and<br />

brain cells that may lead<br />

to Alzheimer’s,<br />

Parkinson’s and motor<br />

neuron disease.<br />

Alzheimer’s disease is<br />

the most common type of<br />

dementia, which includes<br />

memory loss, confusion<br />

and problems with speech<br />

and understanding.<br />

<strong>The</strong> drug is made up of<br />

“supercharged” vitamin<br />

A, which is found in vegetables<br />

like sprouts and carrots<br />

and miniature cabbages, the<br />

Daily Mail reported.<br />

<strong>The</strong> study showed that vitamin<br />

A turns into a chemical<br />

called retinoic acid when broken<br />

down by the body, which is<br />

crucial for the development of<br />

the nervous system.<br />

Higher levels of retinoic<br />

acid in the body could halt<br />

nerve damage and boost the<br />

number of nerve cells. “We are<br />

moving forward with a new<br />

therapeutic which could be<br />

used to help people with<br />

Alzheimer’s disease,” Peter<br />

McCaffery, lead author and<br />

Professor from the Aberdeen<br />

University in Scotland, was<br />

quoted as saying.<br />

“Our work is still at an early<br />

stage but we believe this is a<br />

positive development and the<br />

new drugs seem to protect<br />

nerve cells” he added.<br />

With vitamin A making a<br />

difference, it is important to<br />

find ways of tackling neurological<br />

conditions, McCaffery<br />

said.<br />

In addition, the drug may<br />

also benefit ALS or Lou<br />

Gehrig’s disease, which affects<br />

the muscles of the arms, legs,<br />

mouth and respiratory system.<br />

‘Super drug’ for pediatric blood<br />

cancer may soon be reality<br />

New York, A “super drug”<br />

that helps slow down the progression<br />

of blood cancer in<br />

children could soon become a<br />

reality, say researchers.<br />

Patients with leukemia have<br />

a very low percentage of red<br />

blood cells, making them anemic,<br />

and have approximately<br />

80 times more white blood<br />

cells than people without cancer.<br />

However, the survival rate<br />

is only 30 per cent for children<br />

diagnosed with MLLtranslocation<br />

leukemia, a cancer<br />

that affects the blood and<br />

bone marrow.<br />

“<strong>The</strong>se white blood cells<br />

infiltrate many of the tissues<br />

and organs of the affected individuals<br />

and is a major cause of<br />

death in leukemia patients,”<br />

said Ali Shilatifard, Professor<br />

at the Northwestern University<br />

in the US. “This is a monster<br />

cancer that we’ve been dealing<br />

with for many years in children.<br />

“We’re finally at a point<br />

where in five to 10 years, we<br />

can get a drug in kids that can<br />

be effective. If we can bring<br />

that survival rate up to 85 per<br />

cent, that’s a major accomplishment,”<br />

Shilatifard said. In<br />

the study, detailed in the journal<br />

Genes and Development,<br />

the team demonstrated that<br />

when a key protein responsible<br />

for leukemia, MLL, is stabilised,<br />

it slows the progression<br />

of the leukemia.<br />

This MLL stabilisation<br />

process could potentially work<br />

in cancers with solid tumours,<br />

such as breast or prostate cancer.<br />

<strong>The</strong> next step will be to<br />

combine the treatments from<br />

the past two years of<br />

research into a pediatric<br />

leukemia “super drug” to<br />

test on humans in a clinical<br />

trial, the researchers<br />

said. “This opens up a<br />

new therapeutic approach<br />

not only for leukemia,<br />

which is so important for<br />

the many children who<br />

are diagnosed with this terrible<br />

cancer, but also for other types<br />

of cancers that plague the population,”<br />

the study showed.<br />

<strong>The</strong> team also identified<br />

compounds that could slow<br />

cancer growth by interrupting<br />

a gene transcription process<br />

known as “Super Elongation<br />

Complex” (SEC).<br />

Mindfulness strategies may<br />

help shed excess weight<br />

LONDON : Mindfulness training could be<br />

the key to support weight loss in individuals with<br />

obesity, thereby facilitating healthier eating<br />

behaviours, as per a new study.<br />

Mindfulness is a mind-body<br />

practice where individuals learn<br />

to achieve heightened awareness<br />

of their current state of<br />

mind and immediate environment<br />

in the present moment.<br />

<strong>The</strong> study showed that individuals<br />

who participated in<br />

mindfulness training as part of<br />

an intensive weight management<br />

programme lost three kilograms<br />

of weight in six months<br />

than others who participated in<br />

obesity management programme.<br />

"This research is significant<br />

as we have shown that<br />

problematic eating behaviour<br />

can be improved with mindfulness application,"<br />

said Petra Hansona, lead researcher and postdoctoral<br />

student from the University of<br />

Warwickshire in the UK. "Mindfulness has huge<br />

potential as a strategy for achieving and maintaining<br />

good health and wellbeing," said Thomas<br />

M. Barber, Associate Professor at the varsity.<br />

Focus should be on enabling the populace to<br />

make appropriate lifestyle decisions and empowering<br />

subsequent salutary behaviour change, said<br />

Barber.<br />

For the study, the team examined<br />

weight loss among a small<br />

group of people who were attending<br />

the multidisciplinary tier 3<br />

weight management programme.<br />

Findings, published in the<br />

Journal of Clinical Endocrinology<br />

and Metabolism, showed that individuals<br />

who attended only one or<br />

two courses lost, on average, 0.9<br />

kilograms (2 pounds) during the<br />

same period. Conversely, those<br />

who did not complete the course<br />

tended to weigh more than those<br />

who finished the group mindfulness<br />

course. "Individuals who<br />

completed the course said they<br />

were better able to plan meals in advance and felt<br />

more confident in self-management of weight<br />

loss moving forward," said Hanson. Obesity<br />

worldwide has nearly tripled since 1975, according<br />

to the World Health Organisation. As of<br />

2016, more than 1.9 billion adults worldwide<br />

met the criteria for overweight or obesity.<br />

Women with slim hips may develop diabetes, heart attacks<br />

London : While putting on weight is dangerous<br />

for health, women who have slim hips could<br />

be at risk of diabetes and heart attacks, finds a<br />

new research.<br />

<strong>The</strong> study showed that putting on weight<br />

around the hips is actually safer than accumulation<br />

around the belly or around other major<br />

organs such as the liver or pancreas.<br />

<strong>The</strong> reason could be because some women are<br />

genetically less able to store fat at the hips,<br />

which puts them at risk of Type-2 diabetes and<br />

heart disease.<br />

Also, putting on fat is more likely to circulate<br />

in the blood.<br />

“This means that individuals with this genetic<br />

make-up preferentially store their excess fat in<br />

the liver, muscles or pancreas, or in their blood in<br />

the form of circulating fats and sugar, any of<br />

which can lead to a higher disease risk,” said<br />

Luca Lotta, lead researcher from the University<br />

of Cambridge.<br />

“It may seem counter-intuitive to think that<br />

some people with less fat around their hips are at<br />

higher risk of diabetes or heart disease,” said<br />

Lotta. For the study, the researchers studied the<br />

genetic profiles of more than 600,000 women.<br />

<strong>The</strong>y identified two specific groups of genetic<br />

variants — one that lowers fat around the hips<br />

and another increasing fat around the waist and<br />

belly.<br />

Findings, published in the JAMA medical<br />

journal, showed that both of the genetic variants<br />

identified were associated with higher risk of<br />

Type-2 diabetes and heart attacks.<br />

Genetics which specifically change fat distribution<br />

by lowering fat storage around the hips<br />

increase risk of disease independent of, and in<br />

addition to, mechanisms that affect abdominal<br />

fat storage, the study noted.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!